Syndax Pharmaceuticals (SNDX) Stock: Buy, Sell, or Hold?
SNDX - Syndax Pharmaceuticals, Inc.
$13.40
-0.17 (-1.25%)
▼
5d:
+3.88%
30d:
-25.43%
90d:
-34.7%
HOLD
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 02, 2026
8d
Get Alerted When SNDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: SNDX is currently trading at $13.40, which is considered oversold relative to its 30-day fair value range of $14.38 to $18.48. From a valuation perspective, the stock is trading at a discount (Forward PE: -16.0) compared to its historical average (126.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SNDX is in a strong uptrend. Immediate support is located at $12.79, while resistance sits at $16.95.
Market Sentiment: SNDX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $37.27 (+178.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNDX is in a strong uptrend. Immediate support is located at $12.79, while resistance sits at $16.95.
Market Sentiment: SNDX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $37.27 (+178.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.38 -
$18.48
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
Protect Your Profits
Holding SNDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 178.2% below Wall St target ($37.27)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 13% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$14.38 -
$18.48
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$12.80
Resistance Level
$16.95
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.97
Wall Street Target
$37.27
(+178.2%)
Revenue Growth (YoY)
91.8%
Profit Margin
-87.5%
PE vs Historical
-16.0 vs 126.3
CHEAP
Share & Embed Analysis
Last updated: October 23, 2026 9:34 PM ET
Data refreshes hourly during market hours. Next update: 10:34 PM
Data refreshes hourly during market hours. Next update: 10:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1153 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 49 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 52 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 47 HOLD |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$117 | 53 HOLD |
Advanced SNDX Option Strategies
Professional options setups generated by AI based on today's SNDX price and gamma walls.
